good stocks to invest in now

As Texas considers a “bathroom bill” aimed at transgender individuals, top executives have sent a clear message to the state’s governor: We oppose it.

On Monday, more than 50 business leaders from the Houston area sent a letter to Gov. Greg Abbott, a Republican, asking him to “avoid any actions, including the passage of any ‘bathroom bill,’ that would threaten our continued growth.”

Executives who signed on include the chairman and president of BP America, the CEO of Halliburton (HAL), the CEO of ConocoPhillips (COP), the president of Shell Oil Company and the president of ExxonMobil Global Services Company, a division of ExxonMobil (XOM).

“We support diversity and inclusion, and we believe that any such bill risks harming Texas’ reputation and impacting the state’s economic growth and ability to create new jobs,” the letter reads.

Dallas business leaders sent a similar letter protesting the proposed state law to Abbott earlier this month. That one was signed by Doug Parker, the CEO of American Airlines (AAL), Randall Stephenson, the CEO of AT&T (T, Tech30), and Gary Kelly, the CEO of Southwest Airlines (LUV). (AT&T has agreed to acquire Time Warner, the parent company of CNN. The deal is pending regulatory approval.)

good stocks to invest in now: Mitsubishi Heavy Industries Ltd (MHVYF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Major foreign competitors today now include the French firm Areva (OTCPK:ARVCF) and the Japanese firm Mitsubishi Heavy Industry (OTCPK:MHVYF). This is not a complete list but a focus on major players.

good stocks to invest in now: Humana Inc.(HUM)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday was Humana Inc. (NYSE: HUM) which rose over 4% to $280.36. The stocks 52-week range is $206.68 to $293.35. Volume was 3.2 million compared to the daily average volume of 1.1 million.

  • [By Paul Ausick]

    Late Thursday, reports began to trickle in that retail behemoth Walmart Inc. (NYSE: WMT) was in preliminary negotiations to acquire health insurer Humana Inc. (NYSE: HUM). Humana’s market cap of around $37 billion makes this a very big deal, even if the talks result in some sort of partnership between the two firms.

  • [By ]

    The deal still needs approval from regulators, but there are fewer potential objections than the attempted tie-up between Aetna and Humana (NYSE: HUM), two insurers. While CVS does manage some drug-benefits plans for employers and insurers through its PBM, the merger wouldn’t create less competition in one particular segment of the industry like the insurance market.

  • [By Ben Levisohn]

    Clinton 15 stock basket (DBUSCLNT): UnitedHealth Group (UNH), Humana (HUM), McKesson (MCK), Aecom (ACM), Quanta Services (PWR), ExxonMobil (XOM), Alcoa (AA), NextEra Energy (NEE), Cree (CREE), First Solar (FSLR), Facebook (FB), Netflix (NFLX), Prudential Financial (PRU), Citigroup (C), Union Pacific (UNP).

  • [By Keith Speights]

    Although Aetna wasn’t successful in its attempted merger with Humana (NYSE:HUM), the blocked deal shouldn’t have too much residual effect. Aetna’s share price remains attractively valued, currently trading at 13 times expected earnings.

  • [By Lisa Levin]

    Humana Inc (NYSE: HUM) delivered better than expected results for the third quarter. However, the company’s adjusted EPS forecast came in below the estimates.

good stocks to invest in now: The Bon-Ton Stores, Inc.(BONT)

Advisors’ Opinion:

  • [By Adam Levine-Weinberg]

    Lastly, there are a few department-store chains that have been struggling mightily. Sears tops the list, of course. Bon-Ton Stores (NASDAQ:BONT) and Neiman Marcus are also in serious trouble. All three chains have too much debt and have been reporting some of the worst sales results in the industry.

  • [By Peter Graham]

    The Q3 2016 earnings report for small cap department store stock The Bon-Ton Stores, Inc (NASDAQ: BONT)is scheduled for before the market opens on Thursday (November 17th) as traditional department stores continue to struggle to figure out how to attract costumers into their stores as online giants increasingly become thedominant retail players.

  • [By Peter Graham]

    Small cap department store stock The Bon-Ton Stores, Inc (NASDAQ: BONT) reported Q2 2017 earnings before the market opened on Thursday while earnings guidance for the full year fiscal 2017 was reaffirmed. Total sales decreased 7.0% to $504.4 million as comparable store sales decreased 6.1% versus the prior year period. However,double-digit sales growth continued in the omnichannel, which reflects sales via the Company’s website, mobile site, and its Let Us Find It customer service program, as the Company leveraged its West Jefferson facility and store-fulfillment network. The net loss was $33.2 million versus a net loss of $38.7 million.The CEO commented:

  • [By Paul Ausick]

    The Bon-Ton Stores Inc. (NASDAQ: BONT) dropped about 3.3% Thursday to post a new 52-week low of $0.31 after closing Wednesday at $0.32. The 52-week high is $1.98. Volume was around 10 million shares traded, about 100 times the daily average of around 100,000. The struggling retailer had no specific news.

  • [By Peter Graham]

    Small cap department store stock The Bon-Ton Stores, Inc (NASDAQ: BONT)reported fiscalQ1 earnings before the market opened this morning with total salesdown 9.3% to $536.1 million and comparable store sales down 8.8%. Theearnings release noted:

  • [By Adam Levine-Weinberg]

    Not long ago, liquidation seemed inevitable for bankrupt department store operator Bon-Ton Stores Inc. (NASDAQ:BONT). The company’s desperate attempt to restructure outside the bankruptcy process failed earlier this year when it couldn’t find an investor willing to finance a comeback effort.

good stocks to invest in now: Methanex Corporation(MEOH)

Advisors’ Opinion:

  • [By Jim Robertson]

    Back in February of last year, we suggested Methanex Corporation (MEOH), which ended up providing us with some pretty good gains in a fairly short amount of time, and based on what’s happening with the stock technically right now, it could be another gainer over the next several days to few weeks.

good stocks to invest in now: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By ]

    Cramer was bearish on Geron (GERN) , Mitek Systems (MITK) , AK Steel Holding (AKS) , Sage Therapeutics (SAGE) and AbbVie (ABBV) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By WWW.THESTREET.COM]

    Position: Long GLD small, bonds, SDS; short TLT small, SPY small .

  • [By Chris Lange]

    Shares of Sage Therapeutics Inc. (NASDAQ: SAGE) saw an incredible gain on Thursday after the firm announced positive top-line results from its midstage trial. Specifically, the firm reported results from its Phase 2 trial of Sage-217 for the treatment of moderate to severe major depressive disorder (MDD).

  • [By Lisa Levin]

    SAGE Therapeutics Inc (NASDAQ: SAGE) shares shot up 73 percent to $159.39 after the company disclosed that Phase 2 trial of SAGE-217 met its primary endpoint.

  • [By WWW.THESTREET.COM]

    The Good

    The market remains resistant (Rs over Ss and Ns). Brokerages, banks and insurance companies continue their league-leading strength. The Russell 2000 Index is up for the 15th consecutive day. Retail extends yesterday’s strength. Nordstrom (JWN) , Macy’s (M) , Best Buy (BBY) , Target (TGT) , Walmart (WMT) , Foot Locker (FL) and JCPenney (JCP) are strong. First day down for Amazon (AMZN) . Agricultural commodities are lackluster, but soybeans are up another up $0.05 today, up substantially for three days in a row. Speculative biotech (Sage (SAGE) , FibroGen (FGEN) , Acadia Pharmaceuticals (ACAD) and Aerie Pharmaceuticals  (AERI) ) stronger after recent weakness. Ag equipment up big time after the Deere (DE) beat.

    The Bad

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

Leave a Reply

Your email address will not be published. Required fields are marked *